Lung Cancer Highlights from ASCO 2005-Reference-Cited by-同舟云学术

Lung Cancer Highlights from ASCO 2005

Published:2006-01-01 Issue:1 Volume:11 Page:39-50
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Belvedere Ornella¹,Grossi Francesco²

Affiliation:

1. Department of Medical Oncology, University Hospital, Udine, Italy

2. Medical Oncology A, Disease Management Team - Lung Cancer, National Institute for Cancer, Genoa, Italy

Abstract

Learning Objectives After completing this course, the reader will be able to: Discuss the results of recent trials on the addition of a molecularly targeted agent to standard first-line chemotherapy in NSCLC.Explain the role of surgery in the treatment of stage III NSCLC.Discuss the current status of adjuvant chemotherapy in NSCLC. Access and take the CME test online and receive 1 AMA PRA category 1 credit at CME.TheOncologist.com

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.11-1-39

Reference34 articles.

1. Randomized phase II/III trial of paclitaxel (P) plus carboplatin (C) with or without bevacizumab (NSC #704865) in patients with advanced non-squamous non-small cell lung cancer (NSCLC): an Eastern Cooperative Oncology Group (ECOG) Trial - E4599;Sandler,2005

2. Non-small cell lung cancer and antiangiogenic therapy: what can be expected of bevacizumab?;Herbst;The Oncologist,2004

3. Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer;Johnson;J Clin Oncol,2004

4. A randomized phase III trial comparing bexarotene/cisplatin/vinorelbine versus cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC);Jassem,2005

5. Randomized phase III trial comparing bexarotene/carboplatin/paclitaxel versus carboplatin/paclitaxel in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC);Blumenschein,2005

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nedaplatin/gemcitabine versus carboplatin/gemcitabine in treatment of advanced non-small cell lung cancer: A randomized clinical trial;Chinese Journal of Cancer Research;2012-05-22

2. Prognostic value of single nodal zone metastasis in non-small-cell lung cancer☆;European Journal of Cardio-Thoracic Surgery;2010-10

3. Overview of Efficacy and Limitation of Standard and Targeted Therapy for Malignant Disease Using Lung Cancer as a Case Study;Alternative and Complementary Therapies for Cancer;2010

4. Response to Conventional Therapy and Targeted Molecular Therapy;Molecular Pathology Library;2008

5. Improved non-invasive T-Staging in non-small cell lung cancer by integrated18F-FDG PET/CT;Nuklearmedizin;2007